Illumina said adding SomaLogic would support the company’s multiomics strategy and strengthen the value of its NovaSeq X ...

Up To $425 Million In Total Proceeds Inclusive of Near-term Milestone Payments; $350 Million In Upfront Cash Retains ...

In recent years, Novogene Europe has systematically integrated state-of-the-art technologies across its service portfolio, ...

Illumina is diving deeper into proteomics research with a $425 million plan to acquire SomaLogic, including its protein ...

San Diego gene sequencing giant Illumina is investing more in artificial intelligence to fuel the company’s growth strategy ...

Illumina, Inc. will acquire SomaLogic for $350 million plus performance-based milestones. The acquisition advances Illumina's multiomics strategy, combining SomaLogic's proteomics technology with ...

Mark Field joins the DNA sequencing giant after six years at Insulet, which makes devices for people with diabetes.

Illumina aims to accelerate its current growth by expanding its core sequencing business, entering multiomics, and expanding its services, data, and software business to provide more complete ...

Medical equipment maker Illumina announced on Wednesday its new series of smaller, low-cost benchtop gene sequencers, to make sequencing accessible to more research and testing labs. Skip to main ...

During the first phase of this collaboration, Illumina is working to integrate its existing DRAGEN ... “Combining Illumina’s world-leading sequencing and analytics platforms with Nvidia ...